HNGE · Hinge Health, Inc. · Metrics
$120.95
+5.56 (+4.82%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$9.38B
Shares
81.27M
Volume · Nov 16
569.13K
Avg daily vol (3M)
1.89M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
HNGE metrics
84 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$115.39
Market cap
$9.38B
Price action
23 metricsPrice change (1W)
-0.3%
Price change (30D)
+16.4%
Price change (3M)
+30.4%
Price change (6M)
+111.7%
Price change (YTD)
+148.4%
Price change (1Y)
+176.4%
Trailing year
Price change (5Y)
—
52-week high
$123.23
52-week low
$31.17
Change from 52-week high
-6.4%
Change from 52-week low
+270.2%
Annualized volatility
51.4%
Annualized volatility (3M)
41.6%
Implied volatility (30D)
53.6%
IV rank (1Y)
7.7
IV percentile (1Y)
18.3
Beta
1.2
RSI (14D)
54.7
Price vs SMA 50
+11.1%
Price vs SMA 200
+62.6%
Avg volume (3M)
1.89M
Relative volume
0.8
Average dollar volume
$190.78M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
81.27M
Valuation
12 metricsP / E (TTM)
20.5
Trailing earnings · reciprocal yield 4.9%
PEG ratio
—
EV / revenue
11.3×
reciprocal yield 8.8%
EV / EBITDA
58.3×
reciprocal yield 1.7%
EV / EBIT
60.5×
reciprocal yield 1.7%
P / sales
11.7×
reciprocal yield 8.5%
P / book
31.3
reciprocal yield 3.2%
FCF yield
3.4%
TTM · current market cap
Buyback yield
2.4%
P / FCF
29.1
reciprocal yield 3.4%
P / operating cash flow
29.0
reciprocal yield 3.4%
Earnings yield
1.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-02
Profitability
9 metricsGross margin
85.7%
Operating margin
18.7%
Trailing 12 months
Net margin
21.0%
Gross profit (TTM)
$686.54M
Operating profit (TTM)
$150.09M
Net income (TTM)
$168.31M
Trailing 12 months
Diluted EPS (TTM)
$5.63
FCF margin
40.2%
Effective tax rate
-1.2%
Growth
11 metricsRevenue growth YoY
+52.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$800.82M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+9.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
56.2%
Return on assets
19.3%
Debt / equity
0.0
Current ratio
1.0
EBITDA (TTM)
$155.77M
Free cash flow (TTM)
$322.00M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
-1.4
Return on invested capital
—
Trailing 12 months
Net cash
$211.55M
Latest balance sheet
Cash & equivalents
$211.55M
Total assets
$874.08M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
$322.99M
Capital expenditures (TTM)
$990,000
R&D (TTM)
$134.62M
SG&A (TTM)
—
Stock compensation (TTM)
$67.50M
R&D / revenue
16.8%
Stock compensation / revenue
8.4%
Ownership (13F)
9 metrics13F filers
276
13F filer change QoQ
+73
Institutional ownership
70.8%
Conviction holders (share of 13F filers)
6.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-9.7%
Holder tenure
3.6
Price vs estimated holder cost
+70.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
7.3%
Short interest
3 metricsShort interest
6.1%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
60 / 100
Insider activity
2 metricsNet insider buying (90D)
−$124.48M
Insider-sentiment score
44 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1673743
CUSIP
433313103
13F (30d)
248 filings
245 filers
Visit website
Investor relations